Tabula Rasa HealthCare In... (TRHC)
NASDAQ: TRHC
· Real-Time Price · USD
10.50
0.09 (0.86%)
At close: Nov 02, 2023, 9:00 PM
Tabula Rasa HealthCare Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 90.04M | 88.28M | 82.71M | 77.1M | 72.6M | 67.11M | 85.69M | 86.59M | 82.31M | 76.68M |
Cost of Revenue | 67.51M | 67.52M | 63.02M | 60.23M | 56.63M | 52.72M | 60.9M | 61.16M | 57.26M | 54.03M |
Gross Profit | 22.53M | 20.75M | 19.69M | 16.87M | 15.97M | 14.39M | 24.78M | 25.42M | 25.05M | 22.65M |
Operating Income | -9.03M | -5.3M | -8.8M | -23.65M | -10.09M | -17.91M | -19.06M | -14.75M | -18.77M | -16.75M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -9.61M | -6.97M | -18.35M | -25.89M | -12.53M | -20.18M | -21.21M | -16.98M | -20.95M | -19.29M |
Net Income | -9.85M | -7.07M | -18.37M | -25.88M | -12.69M | -28.19M | -21.37M | -17.11M | -21.08M | -19.49M |
Selling & General & Admin | 20.33M | 19.03M | 18.84M | 30.77M | 17.32M | 18.53M | 26.58M | 23.09M | 26.27M | 23.79M |
Research & Development | 1.78M | 1.28M | 3.26M | 4.02M | 3.24M | 3.96M | 4.9M | 4.98M | 5.92M | 3.99M |
Other Expenses | 566K | 6.2M | 6.39M | 5.72M | 5.49M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 28.21M | 26.51M | 28.49M | 40.52M | 26.05M | 28.23M | 43.84M | 40.17M | 43.81M | 39.4M |
Interest Expense | 1.14M | 1.26M | 1.6M | 2.72M | 2.44M | 2.27M | 2.15M | 2.23M | 2.18M | 2.55M |
Selling & Marketing Expenses | 2.73M | 2.45M | 2.81M | 2.86M | 2.17M | 2.65M | 7.18M | 6.22M | 6.32M | 6.25M |
Cost & Expenses | 95.72M | 94.03M | 91.51M | 100.75M | 82.69M | 80.95M | 104.75M | 101.33M | 101.08M | 93.43M |
Income Tax Expense | 133K | 105K | 21K | -7K | 159K | 216K | 161K | 134K | 133K | 199K |
Shares Outstanding (Basic) | 25.42M | 25.24M | 24.94M | 24.35M | 23.96M | 23.87M | 23.47M | 23.41M | 23.27M | 23.01M |
Shares Outstanding (Diluted) | 25.42M | 25.24M | 24.94M | 24.35M | 23.96M | 23.87M | 23.47M | 23.41M | 23.27M | 23.01M |
EPS (Basic) | -0.39 | -0.28 | -0.74 | -1.06 | -0.53 | -1.18 | -0.91 | -0.73 | -0.91 | -0.85 |
EPS (Diluted) | -0.39 | -0.28 | -0.74 | -1.06 | -0.53 | -1.18 | -0.91 | -0.73 | -0.91 | -0.85 |
EBITDA | -3.29M | 896K | -1.82M | -19.33M | -4.6M | -3.97M | -6.7M | -2.65M | -7.15M | -5.12M |
EBIT | -8.47M | -6.1M | -16.75M | -23.17M | -10.09M | -21.97M | -10.78M | -14.75M | -18.77M | -16.75M |
Depreciation & Amortization | 6.1M | 6.2M | 6.98M | 6.2M | 5.49M | 13.07M | 12.36M | 12.1M | 11.62M | 11.63M |